Drug Discovery Services Market worth US$27.23 billion in 2030 with 10.7% CAGR | MarketsandMarketsâ„¢
The global Drug Discovery Services Market , valued at US$14.89 billion in 2024, is forecasted to grow at a robust CAGR of ...
In the last year, some drugmakers have pulled back from the sector, including Pfizer, which recently stopped selling its gene ...
President Donald Trump's blunt-force use of tariffs has forged a rare bipartisan alliance among Kentucky's top leaders ...
The FBI is now involved in the investigation into a suspected arson earlier this month at a Bayer pharmaceutical executive's home.
Kennedy and others in Trump's orbit have found a particularly warm reception among some of the biggest supplement evangelists ...
In a report released on March 10, Charles Weston from RBC Capital maintained a Hold rating on Alliance Pharma (APH – Research Report), with a price target of p64.75. The company’s shares ...
A Wiltshire-based healthcare firm has backed an increased takeover bid worth a whopping £362 million. Alliance Pharma, based at Avonbridge House in Chippenham, has been the subject of an offer worth ...
Alliance Pharma (LON: APH) has accepted a final increased cash offer from investment firm DBAY Advisors, valuing the pharmaceutical company at approximately £362 million ($468 million). The board of ...
Shah is advising on IP. Hengeler Mueller advised Sycamore in relation to WBA’s significant German business assets, particularly Frankfurt-based pharmaceutical giant Alliance Healthcare Deutschland. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results